These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 19339104

  • 1. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL, Xu YM, Bao W, Fu HJ, Wu CG, Zhao Y, Li ZK, Zhang J, Li SQ, Chen WQ, Wang T, Zhang R, Zhang LH, Qian GS, Chen SY, Jia LT, Yang AG.
    Cancer Lett; 2009 Aug 28; 281(2):134-43. PubMed ID: 19339104
    [Abstract] [Full Text] [Related]

  • 2. Investigation of HER2 overexpression in non-small cell lung cancer.
    Ugocsai K, Mándoky L, Tiszlavicz L, Molnár J.
    Anticancer Res; 2005 Aug 28; 25(4):3061-6. PubMed ID: 16080566
    [Abstract] [Full Text] [Related]

  • 3. [Effects of Her-2/neu siRNA-mediated gene silencing on cell cycle and apoptosis of lung adenocarcinoma cells].
    Ren SH, Wang JW, Zhang L.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 15; 85(22):1530-4. PubMed ID: 16179111
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
    Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H, Shen J, Zhao RY, Caraway NP, Katz RL, Stass SA, Jiang F.
    Cancer Res; 2007 Aug 15; 67(16):7901-6. PubMed ID: 17699796
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
    Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D, Hölscher AH, Danenberg PV.
    Clin Cancer Res; 2001 Jul 15; 7(7):1850-5. PubMed ID: 11448895
    [Abstract] [Full Text] [Related]

  • 6. Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy.
    Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T, Sasano H.
    Cancer Res; 2005 Jul 15; 65(14):6450-8. PubMed ID: 16024650
    [Abstract] [Full Text] [Related]

  • 7. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282
    [Abstract] [Full Text] [Related]

  • 8. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.
    Pellegrini C, Falleni M, Marchetti A, Cassani B, Miozzo M, Buttitta F, Roncalli M, Coggi G, Bosari S.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3645-52. PubMed ID: 14506153
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA, Nemunaitis J, Samuel SK, Chen P, Shen Y, Tong AW.
    Cancer Res; 2006 Oct 01; 66(19):9736-43. PubMed ID: 17018633
    [Abstract] [Full Text] [Related]

  • 10. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R, Eguchi K, Takahashi M, Goldman S, Okano H, Kawase T, Yazaki T.
    J Gene Med; 2006 Nov 01; 8(11):1329-40. PubMed ID: 16955534
    [Abstract] [Full Text] [Related]

  • 11. HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy.
    Junker K, Stachetzki U, Rademacher D, Linder A, Macha HN, Heinecke A, Müller KM, Thomas M.
    Lung Cancer; 2005 Apr 01; 48(1):59-67. PubMed ID: 15777971
    [Abstract] [Full Text] [Related]

  • 12. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q, Zhao XY, Bai RZ, Liang SF, Nie CL, Yuan Z, Wang CT, Wu Y, Chen LJ, Wei YQ.
    Oncol Rep; 2009 Nov 01; 22(5):1069-75. PubMed ID: 19787223
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.
    Bulk E, Hascher A, Liersch R, Mesters RM, Diederichs S, Sargin B, Gerke V, Hotfilder M, Vormoor J, Berdel WE, Serve H, Müller-Tidow C.
    Cancer Res; 2008 Mar 15; 68(6):1896-904. PubMed ID: 18339871
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY, Xia W, Shao R, Hung MC.
    Oncogene; 1996 Oct 03; 13(7):1405-12. PubMed ID: 8875978
    [Abstract] [Full Text] [Related]

  • 15. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S, Machado-Pinilla R, Manguan-García C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeño J, Casado E, Nistal M, Gonzalez-Barón M, Perona R.
    Oncogene; 2006 Jun 01; 25(23):3335-45. PubMed ID: 16462770
    [Abstract] [Full Text] [Related]

  • 16. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP, Jiang GC, Yang F, Zhou ZL, Wang J.
    Zhonghua Wai Ke Za Zhi; 2007 Sep 15; 45(18):1267-70. PubMed ID: 18067742
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J, Ren H, Yuan P, Lang W, Zhang L, Mao L.
    Cancer Res; 2006 Jan 01; 66(1):18-23. PubMed ID: 16397209
    [Abstract] [Full Text] [Related]

  • 18. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC.
    Cancer Res; 1994 Jun 15; 54(12):3260-6. PubMed ID: 7911396
    [Abstract] [Full Text] [Related]

  • 19. HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer.
    Yoshino I, Goedegebuure PS, Peoples GE, Parikh AS, DiMaio JM, Lyerly HK, Gazdar AF, Eberlein TJ.
    Cancer Res; 1994 Jul 01; 54(13):3387-90. PubMed ID: 7912166
    [Abstract] [Full Text] [Related]

  • 20. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C, Daigo Y, Ishikawa N, Kato T, Hayama S, Ito T, Tsuchiya E, Nakamura Y.
    Cancer Res; 2005 Dec 15; 65(24):11314-25. PubMed ID: 16357138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.